Public Company News

CGI in the Asia Pacific hosts CGI Elevate 2025 to spark conversations on the future of Global Capability Centers

CGI brings together industry leaders to discuss the evolution of Global Capability Centers (GCCs) into hubs of innovation and growth in an AI-driven landscape. BANGALORE, India, March 11, 2025 /PRNewswire/ -- CGI  (TSX: GIB.A) (NYSE: GIB), one of the largest indepe...

2025-03-11 10:00 3105

Agoda Survey Reveals: Strong Interest in Family Travel and New Destinations Among South Korean Women

SEOUL, South Korea, March 11, 2025 /PRNewswire/ -- To mark International Women's Day which took place onMarch 8, digital travel platform Agoda unveiled travel insights about South Korean women. The findings revealed that while both men and women plan to travel more in 2025, South Korean women are...

2025-03-11 08:05 5645

Harbour BioMed Appoints Michael D. Patten as Chief Strategy Officer

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 10, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immunology and oncology, today announced ...

2025-03-11 08:00 2392

Harbour BioMed Appoints Dr. Ian Y. Liu as Global Head of Legal

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 10, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immunology and oncology, today announced ...

2025-03-11 08:00 2364

Hesai Selected by Top European OEM For Exclusive Multi-Year Lidar Contract On Its Next-Generation Global Platform

PALO ALTO, Calif., March 10, 2025 /PRNewswire/ -- Hesai Technology (NASDAQ: HSAI), the global leader in lidar technology for automotive mobility and robotics applications, announced today a new exclusive design win with a leading European OEM. Hesai will provide advanced ultra-long-range automoti...

2025-03-11 06:09 3421

Yalla Group Limited Announces Unaudited Fourth Quarter and Full Year 2024 Financial Results

DUBAI, UAE, March 10, 2025 /PRNewswire/ -- Yalla Group Limited ("Yalla" or the "Company") (NYSE: YALA), the largestMiddle East and North Africa (MENA)-based online social networking and gaming company, today announced its unaudited financial results for the fourth quarter and full year endedDecem...

2025-03-11 05:00 4367

Protecting Women's Health: Visionary's Precision Cervical Cancer Screening Public Welfare Activity Brings Health Blessings to Women

TORONTO, March 10, 2025 /PRNewswire/ -- On March 8, 2025, the public welfare activity of "Celebrating International Women's Day and Caring for Women's Health" and the "Global Press Conference of E7 Protein Detection Kit" were successfully held inHong Kong, China. This event was hosted by (Canada)...

2025-03-11 04:00 6537

Macronix OctaFlash Provides High-Performance Memory for New STMicroelectronics' STM32N6 AI-Accelerated MCU Platform

1Gb OctaFlash™ Memory Helps Enable Advanced AI Applications, 3D-like GUI Experience HSINCHU, March 10, 2025 /PRNewswire/ -- Macronix International Co., Ltd. (TSE: 2337), a leading integrated device manufacturer in the non-volatile memory (NVM) m...

2025-03-11 00:00 3637

Gan & Lee Pharmaceuticals Announced First Participant Dosed in the US Phase 2 Clinical Study of Bofanglutide (GZR18) Injection for Overweight or Obesity

BEIJING and BRIDGEWATER, N.J., March 10, 2025 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087) announced that the first participant has been successfully dosed in a Phase 2 clinical trial of bofanglutide (research code: GZR18) injection, a bi-weekly glucagon-...

2025-03-10 23:45 4273

TCI Biotech Announces Strong 2024 Financial Performance, Sets Sights on Global Growth in 2025

TAIPEI, March 10, 2025 /PRNewswire/ -- TCI Biotech (TCI Co., Ltd.) (TWSE: 8436), a leading CDMO+ innovator in health food and skincare biotechnology, has released its consolidated financial results for the fiscal year endingDecember 31, 2024. The company reported steady revenue performance, stron...

2025-03-10 23:00 3498

/C O R R E C T I O N -- Newmark Group, Inc./

In the news release, Newmark Report: Resilient Singapore Office Demand Backed by Steady Economic Growth, issued06-Mar-2025 by Newmark Group, Inc. over PR Newswire, we are advised by the company that the first sentence of the release should read "Newmark has released a study on theSingapore office...

2025-03-10 22:45 7180

K. A. Prabhakaran Appointed Senior Vice President and Chief Technology Officer of Cyient

HYDERABAD, India and DALLAS, March 10, 2025 /PRNewswire/ -- Cyient Limited, a global Intelligent Engineering solutions company, announced the appointment of K. A. Prabhakaran as Senior Vice President and Chief Technology Officer of its DET business. Prabhakaran is an accomplished professional in...

2025-03-10 21:15 2446

World's First Large-Scale, Multicenter Prospective Study in Single-Reading Mammography Confirms Lunit AI Boosts Cancer Detection

Prospective study finds Lunit AI increases cancer detection by 13.8% in single-reader settings without raising recall rates, presenting a game-changing tool for countries relying on single-reader mammography screening SEOUL, South Korea, March 10, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a le...

2025-03-10 21:00 3099

Agora Launches Conversational AI Toolkit for IoT Devices

New partnerships with Beken and Robopoet showcase the future of interactive toys and connected devices SANTA CLARA, Calif., March 10, 2025 /PRNewswire/ -- Agora, Inc. (NASDAQ: API), a global leader in real-time engagement solutions, is expanding into AI-powered robotics and interactive toys with...

2025-03-10 21:00 2577

Visionary Takes the Lead in the New Energy Vehicle Field and Builds an Innovative Industrial Ecosystem

TORONTO, March 10, 2025 /PRNewswire/ -- Recently, Visionary announced that it will make a major foray into the new energy vehicle industry and build a unique integrated industrial ecosystem of "vehicle-station-power-cloud-research-finance". It is committed to creating a new industry landscape in...

2025-03-10 21:00 4150

CBAK Energy to Report fourth quarter & full year 2024 Unaudited Financial Results on Monday, March 17, 2025

DALIAN, China, March 10, 2025 /PRNewswire/ -- CBAK Energy Technology, Inc. (NASDAQ: CBAT) ("CBAK Energy", or the "Company"), a leading lithium-ion battery manufacturer and electric energy solution provider in China, today announced that it will report its unaudited financial results for the fourt...

2025-03-10 21:00 3166

NYSE Content advisory: Pre-market update for March 10th

NEW YORK, March 10, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content advisory: Pre-market update for March 10...

2025-03-10 20:57 3367

NYSE CONTENT ADVISORY: New York Stock Exchange Partnership Network Update

NEW YORK, March 10, 2025 /PRNewswire/ -- At the inaugural New York Stock Exchange Partnership Day, the NYSE put out a call to action by bringing together leading media partners, publishers, ad tech leaders, content creators, agencies, and platforms to launch the NYSE Partnership Network. Here is ...

2025-03-10 20:50 3511

SunCar Wins Contract to Build Insurance Platform for Major EV Maker Leapmotor

NEW YORK, March 10, 2025 /PRNewswire/ -- SunCar Technology Group Inc. ("SunCar" or the "Company") (NASDAQ: SDA), an innovative leader in auto e-insurance and cloud-based B2B auto services inChina, today announced it has secured a contract to develop and operate the insurance management platform f...

2025-03-10 20:45 3761

Kelun-Biotech's TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) Approved for Marketing in Second Indication by NMPA for EGFRm NSCLC

CHENGDU, China, March 10, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company's trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, formerly SKB264/MK-2870) was approved ...

2025-03-10 19:22 2548

Week's Top Stories